BNC2, a TF previously associated with a mesenchymal breast cancer stem cell phenotype (50), is particularly strongly mesenchymal specific (Supplementary Figure S4B–D), and is consistently responsive to miR-200c perturbation across cell lines (Figure 3, Supplementary Figures S2,S3). The gene discussed is BNC2; the disease is breast cancer.